BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19111861)

  • 1. Nightmares and memantine: a case report and review of literature.
    Iraqi A; Hughes TL
    J Am Med Dir Assoc; 2009 Jan; 10(1):77-8. PubMed ID: 19111861
    [No Abstract]   [Full Text] [Related]  

  • 2. Memantine Exacerbates Corrected QT Interval Prolongation in Alzheimer's Disease: A Case Report from an Unintentional Rechallenge.
    Kajitani K; Yanagimoto K; Monji A; Maruyama T
    J Am Geriatr Soc; 2016 Jan; 64(1):232-3. PubMed ID: 26782892
    [No Abstract]   [Full Text] [Related]  

  • 3. Seizures associated with memantine use.
    Peltz G; Pacific DM; Noviasky JA; Shatla A; Mehalic T
    Am J Health Syst Pharm; 2005 Feb; 62(4):420-1. PubMed ID: 15745897
    [No Abstract]   [Full Text] [Related]  

  • 4. Pilot trial of memantine in primary progressive aphasia.
    Johnson NA; Rademaker A; Weintraub S; Gitelman D; Wienecke C; Mesulam M
    Alzheimer Dis Assoc Disord; 2010; 24(3):308. PubMed ID: 20798612
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholinesterase inhibitors and memantine for symptomatic treatment of dementia.
    Rodda J; Carter J
    BMJ; 2012 May; 344():e2986. PubMed ID: 22550350
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and tolerability of once-daily versus twice-daily memantine: a randomised, double-blind study in moderate to severe Alzheimer's disease.
    Jones RW; Bayer A; Inglis F; Barker A; Phul R
    Int J Geriatr Psychiatry; 2007 Mar; 22(3):258-62. PubMed ID: 17243195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Memantine-associated renal impairment in a patient with Alzheimer's disease.
    Horikawa N; Yamada H; Uchimura N
    Psychiatry Clin Neurosci; 2013 Feb; 67(2):126. PubMed ID: 23438167
    [No Abstract]   [Full Text] [Related]  

  • 8. Memantine for AIDS dementia complex: open-label report of ACTG 301.
    Zhao Y; Navia BA; Marra CM; Singer EJ; Chang L; Berger J; Ellis RJ; Kolson DL; Simpson D; Miller EN; Lipton SA; Evans SR; Schifitto G;
    HIV Clin Trials; 2010; 11(1):59-67. PubMed ID: 20400412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alzheimer dementia. Memantine: value for patient and caregivers].
    MMW Fortschr Med; 2009 Nov; 151(45):44-5. PubMed ID: 19960725
    [No Abstract]   [Full Text] [Related]  

  • 10. ACP Journal Club. Review: cholinesterase inhibitors but not memantine increase syncope in older adults with mild cognitive impairment or dementia.
    Ng B
    Ann Intern Med; 2011 Nov; 155(10):JC5-10. PubMed ID: 22084357
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic study of memantine in healthy and renally impaired subjects.
    Periclou A; Ventura D; Rao N; Abramowitz W
    Clin Pharmacol Ther; 2006 Jan; 79(1):134-43. PubMed ID: 16413248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deterioration in donepezil-induced PR prolongation after a coadministration of memantine in a patient with Alzheimer's disease.
    Igeta H; Suzuki Y; Motegi T; Sasaki A; Yokoyama Y; Someya T
    Gen Hosp Psychiatry; 2013; 35(6):680.e9-10. PubMed ID: 23731891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine for Alzheimer's disease.
    Med Lett Drugs Ther; 2003 Sep; 45(1165):73-4. PubMed ID: 12968123
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of memantine to treat Alzheimer's disease.
    Gauthier S; Herrmann N; Ferreri F; Agbokou C
    CMAJ; 2006 Aug; 175(5):501-2. PubMed ID: 16940271
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
    Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
    Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
    [No Abstract]   [Full Text] [Related]  

  • 16. Memantine standard tablet and extended-release dosing considerations: a pharmacokinetic analysis.
    Lam S; Smith C; Gomolin IH
    J Am Geriatr Soc; 2015 Feb; 63(2):383-4. PubMed ID: 25688611
    [No Abstract]   [Full Text] [Related]  

  • 17. I remember.
    Ladouceur R
    Can Fam Physician; 2006 Feb; 52():155. PubMed ID: 16529383
    [No Abstract]   [Full Text] [Related]  

  • 18. Memantine: pharmacological properties and clinical uses.
    Kumar S
    Neurol India; 2004 Sep; 52(3):307-9. PubMed ID: 15472417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 6-month, open-label study of memantine in patients with frontotemporal dementia.
    Diehl-Schmid J; Förstl H; Perneczky R; Pohl C; Kurz A
    Int J Geriatr Psychiatry; 2008 Jul; 23(7):754-9. PubMed ID: 18213609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memantine in the treatment and prophylaxis of bipolar II disorder and comorbid fibromyalgia: a case report.
    Serra G; DE Chiara L; Koukopoulos AE; Koukopoulos A; Serra G; Kahn DA
    J Psychiatr Pract; 2014 May; 20(3):232-6. PubMed ID: 24847998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.